tiprankstipranks
Advertisement
Advertisement

AU:PER Stock Latest News

Percheron secures funding and key conference slots to advance HMBD-002 into phase II
Company AnnouncementsPercheron secures funding and key conference slots to advance HMBD-002 into phase II
10h ago
Percheron Therapeutics Issues 131 Million Unquoted Options at $0.01 Exercise Price
PremiumCompany Announcements
Percheron Therapeutics Issues 131 Million Unquoted Options at $0.01 Exercise Price
8d ago
Percheron Therapeutics Seeks ASX Quotation for 262.9 Million New Shares
PremiumCompany Announcements
Percheron Therapeutics Seeks ASX Quotation for 262.9 Million New Shares
8d ago
Percheron’s VISTA-Targeting Cancer Drug Clears Key Phase I Safety Hurdle
PremiumCompany Announcements
Percheron’s VISTA-Targeting Cancer Drug Clears Key Phase I Safety Hurdle
9d ago
Percheron Therapeutics Updates ASX Filing on Unquoted Equity Securities
PremiumCompany Announcements
Percheron Therapeutics Updates ASX Filing on Unquoted Equity Securities
15d ago
Percheron Therapeutics Corrects ASX Filing on Unquoted Equity Securities
PremiumCompany AnnouncementsPercheron Therapeutics Corrects ASX Filing on Unquoted Equity Securities
15d ago
Percheron Therapeutics Issues 27.5 Million Unquoted Options Expiring in 2028
Premium
Company Announcements
Percheron Therapeutics Issues 27.5 Million Unquoted Options Expiring in 2028
15d ago
Percheron Therapeutics Issues 50 Million Unquoted Options Expiring in 2028
Premium
Company Announcements
Percheron Therapeutics Issues 50 Million Unquoted Options Expiring in 2028
15d ago
Percheron Director Increases Stake Through Entitlement Offer
PremiumCompany Announcements
Percheron Director Increases Stake Through Entitlement Offer
15d ago
Percheron Therapeutics Issues 86 Million Unquoted Options Expiring 2028
PremiumCompany Announcements
Percheron Therapeutics Issues 86 Million Unquoted Options Expiring 2028
15d ago
Percheron Therapeutics Seeks ASX Quotation for 172 Million New Shares
PremiumCompany Announcements
Percheron Therapeutics Seeks ASX Quotation for 172 Million New Shares
15d ago
Percheron Raises $2.2m to Advance HMBD-002 Towards Phase II Trial
PremiumCompany Announcements
Percheron Raises $2.2m to Advance HMBD-002 Towards Phase II Trial
16d ago
Percheron Sets Closing Date for Entitlement Offer to Fund Therapeutic Pipeline
PremiumCompany AnnouncementsPercheron Sets Closing Date for Entitlement Offer to Fund Therapeutic Pipeline
28d ago
Percheron to Showcase New HMBD-002 Cancer Data at ASCO 2026
Premium
Company Announcements
Percheron to Showcase New HMBD-002 Cancer Data at ASCO 2026
1M ago
Percheron Therapeutics Launches Discounted Entitlement Offer, Excludes Overseas Holders
Premium
Company Announcements
Percheron Therapeutics Launches Discounted Entitlement Offer, Excludes Overseas Holders
1M ago
Percheron Therapeutics Launches Non-Renounceable Entitlement Offer With Free-Attaching Options
PremiumCompany Announcements
Percheron Therapeutics Launches Non-Renounceable Entitlement Offer With Free-Attaching Options
1M ago
Percheron Therapeutics Launches Discounted Entitlement and Shortfall Offer
PremiumCompany Announcements
Percheron Therapeutics Launches Discounted Entitlement and Shortfall Offer
2M ago
Percheron Therapeutics Plans Issue of 50 Million Unquoted Options
PremiumCompany Announcements
Percheron Therapeutics Plans Issue of 50 Million Unquoted Options
2M ago
Percheron Therapeutics Plans Large Pro Rata Capital Raising on ASX
PremiumCompany Announcements
Percheron Therapeutics Plans Large Pro Rata Capital Raising on ASX
2M ago
Percheron Updates Timetable for $2.2m Entitlement Offer Ahead of 2026 Trials
PremiumCompany AnnouncementsPercheron Updates Timetable for $2.2m Entitlement Offer Ahead of 2026 Trials
2M ago
Percheron Therapeutics Launches Pro Rata Rights Offer at Discounted Issue Price
Premium
Company Announcements
Percheron Therapeutics Launches Pro Rata Rights Offer at Discounted Issue Price
2M ago
Percheron Therapeutics Launches Discounted Entitlement Offer to Fund HMBD-002 Trial
Premium
Company Announcements
Percheron Therapeutics Launches Discounted Entitlement Offer to Fund HMBD-002 Trial
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >